Articles

Friday Pearls

Friday Pearls

Biosyntrx Response to Vitamin E Hysteria

Friday, November 12, 2004

A meta-analysis on synthetic vitamin E and all-cause mortality published November 10th, 2004 in the on-line issue of Annals of Internal Medicine inappropriately tries to draw conclusions for the whole population based on a combination of studies of people who were already at risk with existing diseases including heart disease, cancer, Alzheimer's, Parkinson's and kidney failure.

Zinc Controversy

Friday, November 05, 2004

Recent science suggests that even mild zinc deficiency contributes to a number of health problems. However, a number of controlled trials strongly suggest that zinc supplementation should not excessively exceed the safe upper level (UL) established by the Food and Nutrition Board of The Institute of Medicine. Zinc plays an important role in the prevention of a number of age related diseases:

Biosyntrx Launches Oculair at AAO

Friday, October 29, 2004

Biosyntrx announces their newly named next-generation Syntrx Complete multiple formulation for eyes and body health at the 2004 American Academy of Ophthalmology meeting in New Orleans.

Macula Complete Cited ''Best In Class''

Friday, October 22, 2004

Macula Complete has received the endorsement of Macular Degeneration Support, the award-winning, worldwide Internet-based information and support community for people affected by macular degeneration and similar retinal diseases. Founded in 1995, MD Support is an independent, non-profit organization which as a practice avoids product recommendations. Nevertheless, Dan Roberts, founder and director of MD Support, lauded Macula Complete in an e-mail to the organization's members earlier this month:

Vascular Disease and Folate

Thursday, October 14, 2004

Women consuming 800 mcgs, or more, of folate (folic acid) per day have a significantly lower risk of developing high blood pressure than women consuming lesser amounts.

Do No Harm

Friday, October 01, 2004

Research to Prevent Blindness contributed to the funding of an important study published in the July 2004 issue of Ophthalmology on four classes of prescription drugs associated with adverse ocular drug reactions. The use of bisphosphonates, cetirizine, retinoids, and topiramate can cause moderate to severe ocular side effects.

Molecular Biology's New Toy: The Microarray

Friday, September 24, 2004

Instead of examining one gene at a time researchers can now look at tens of thousands of genes simultaneously. The microarray (a new research tool that combines molecular biology and computers) allows researchers to take samples of tissues and process them in such a way as to isolate the specific molecules between deoxyribonucleic acid (DNA), the molecules that carry all the genetic information necessary for the organization and functioning of most living cells, and mRNA (ribonucleic acid), the messenger protein peptides, which translates the information encoded in our DNA.

Lycopene: Cataracts and Lipofuscin

Friday, September 17, 2004

Of all the carotenoids, lycopene has been shown to exhibit the highest physical quenching rate of singlet oxygen. Lycopene has very high antioxidative activity and exerts a protective effect from various diseases, including cataracts, aging of retinal pigment epithelial cells, prostate cancer and lower urinary tract symptoms in older men.

Selenium and Homocysteine

Friday, September 10, 2004

Researchers have determined that elderly humans with low selenium concentrations have increased levels of the cardiovascular risk factor known as homocysteine.

New Beta-Carotene and Smokers Data From the Infamous Finnish ATBC study.

Friday, September 03, 2004

An important new study published in the July issue of the American Journal of Epidemiology suggests that smokers who consume a wide variety of dietary antioxidants, including reasonable amounts of beta carotene, have a substantially lower risk of developing lung cancer. Scientists from a number of universities, including Yale, together with resea...

Pages:  1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27  |  28  |  29  |  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  |  41  |  42  |  43  |  44  |  45  |  46  |  47  |  48